Unusual radiological and histological presentation of a diffuse leptomeningeal glioneuronal tumor (DLGNT) in a 13-year-old girl
- 146 Downloads
Diffuse leptomeningeal glioneuronal tumors (DLGNTs) are newly recognized as an entity in the 2016 revision of the WHO Classification of tumors of the central nervous system. They typically present as diffuse leptomeningeal infiltrates along the neuraxis with focal and superficial involvement of the parenchyma. Here, we report a DLGNT with unusual radiological and histological features. A 13-year-old girl presented with scoliosis and back pain. Magnetic resonance imaging demonstrated a syrinx from C2 to T11 and an intramedullary mass from T6 to T9–10. No leptomeningeal involvement was recognized. Histological examination of the gross total resection specimen revealed a low-grade neuroepithelial neoplasm predominantly infiltrating the spinal cord and only focally involving the leptomeninges. Chromosome microarray identified co-deletion of the short arm of chromosome 1 and the long arm of chromosome 19 as well as fusion of the KIAA1549 and BRAF genes. Next-generation sequencing demonstrated wild-type alleles at the mutational hotspots of IDH1 (R132) and IDH2 (R140 and R172). In contrast to most reported DLGNTs, the tumor described in this manuscript was characterized by a predominant parenchymal component and only minor leptomeningeal involvement both radiographically and histologically. Our case, therefore, expands the spectrum of radiological and histopathological features of this new entity. It also highlights the critical role of molecular genetic testing in establishing the diagnosis of DLGNT in unusual cases.
KeywordsDiffuse leptomeningeal glioneuronal tumors (DLGNT) BRAF KIAA1549-BRAF fusion 1p/19q co-deletion Scoliosis Syrinx
We would like to sincerely thank the patient and her family members for allowing us to report this case.
Compliance with ethical standards
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- 1.Reifenberger G, Rodriguez F, Burger PC, Perry A, Capper D (2016) In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) Diffuse leptomeningeal glioneuronal tumour. World Health Organization histological classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon, pp 152–155Google Scholar
- 10.Armao DM, Stone J, Castillo M, Mitchell KM, Bouldin TW, Suzuki K (2000) Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. AJNR Am J Neuroradiol 21(6):1122–1126Google Scholar
- 13.Gardiman MP, Fassan M, Nozza P, Orvieto E, Garre ML, Milanaccio C, Severino M, Perilongo G, Giangaspero F (2012) Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up. Pathologica 104(6):428–431Google Scholar
- 15.Pellerino A, Ruda R, Bertero L, Magistrello M, Franchino F, Cassoni P, Pasqualetti F, Pinessi L, Giangaspero F, Soffietti R (2018) Successful use of bevacizumab in an adult primary diffuse leptomeningeal glioneuronal tumor. J Neurosurg Sci 62(2):229–232Google Scholar
- 18.Dodgshun AJ, SantaCruz N, Hwang J, Ramkissoon SH, Malkin H, Bergthold G, Manley P, Chi S, MacGregor D, Goumnerova L, Sullivan M, Ligon K, Beroukhim R, Herrington B, Kieran MW, Hansford JR, Bandopadhayay P (2016) Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation. J Neuro-Oncol 128(2):293–302CrossRefGoogle Scholar